Human Genome Epidemiology Literature Finder
Records 1 - 28 (of 28 Records) |
Query Trace: Neoplasms and SLCO1B3[original query] |
---|
Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics. Clinical pharmacology and therapeutics 2007 Jan 81 (1): 76-82. Smith NF, Marsh S, Scott-Horton TJ, Hamada A, Mielke S, Mross K, Figg WD, Verweij J, McLeod HL, Sparreboom A |
Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Therapeutic drug monitoring 2008 Oct 30 (5): 559-64. Miura Masatomo, Kagaya Hideaki, Satoh Shigeru, Inoue Kazuyuki, Saito Mitsuru, Habuchi Tomonori, Suzuki Tosh |
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJU international 2008 Aug 102 (5): 617-21. Sharifi Nima, Hamada Akinobu, Sissung Tristan, Danesi Romano, Venzon David, Baum Caitlin, Gulley James L, Price Douglas K, Dahut William L, Figg William |
Influence of solute carriers on the pharmacokinetics of CYP3A4 probes. Clinical pharmacology and therapeutics 2008 Dec 84 (6): 704-9. Franke R M, Baker S D, Mathijssen R H, Schuetz E G, Sparreboom |
Telmisartan pharmacokinetics in Japanese renal transplant recipients. Clinica chimica acta; international journal of clinical chemistry 2009 Jan 399 (1-2): 83-7. Miura Masatomo, Satoh Shigeru, Inoue Kazuyuki, Saito Mitsuru, Habuchi Tomonori, Suzuki Tosh |
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast cancer research and treatment 2011 Jan 125 (2): 563-9. Justenhoven Christina, Schaeffeler Elke, Winter Stefan, Baisch Christian, Hamann Ute, Harth Volker, Rabstein Sylvia, Spickenheuer Anne, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Schwab Matthias, Brauch Hiltr |
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 29 (18): 2565-73. Yang Ming, Xie Wanling, Mostaghel Elahe, Nakabayashi Mari, Werner Lillian, Sun Tong, Pomerantz Mark, Freedman Matthew, Ross Robert, Regan Meredith, Sharifi Nima, Figg William Douglas, Balk Steven, Brown Myles, Taplin Mary-Ellen, Oh William K, Lee Gwo-Shu Mary, Kantoff Philip |
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer chemotherapy and pharmacology 2011 Jun 67 (6): 1471-8. Chew Sin-Chi, Singh Onkar, Chen Xiangai, Ramasamy Rathi Devi, Kulkarni Tejal, Lee Edmund J D, Tan Eng-Huat, Lim Wan-Teck, Chowbay Balr |
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients. British journal of clinical pharmacology 2012 Apr 73 (4): 606-18. Chew Sin Chi, Sandanaraj Edwin, Singh Onkar, Chen Xiangai, Tan Eng Huat, Lim Wan Teck, Lee Edmund J D, Chowbay Balr |
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Apr 20 (4): 619-27. Wright Jonathan L, Kwon Erika M, Ostrander Elaine A, Montgomery R Bruce, Lin Daniel W, Vessella Robert, Stanford Janet L, Mostaghel Elahe |
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenetics and genomics 2013 Jan 23 (1): 29-33. Lewis Lionel D, Miller Antonius A, Owzar Kouros, Bies Robert R, Markova Svetlana, Jiang Chen, Kroetz Deanna L, Egorin Merrill J, McLeod Howard L, Ratain Mark J, |
Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation. Prostate cancer and prostatic diseases 2013 Dec 16 (4): 336-40. Fujimoto N, Kubo T, Inatomi H, Bui H T T, Shiota M, Sho T, Matsumoto |
SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk. Cancer investigation 2014 Jul 32 (6): 256-61. Bui Hoai Thi Thu, Fujimoto Naohiro, Kubo Tatsuhiko, Inatomi Hisato, Matsumoto Tetsu |
ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors. SpringerPlus 2015 4 327. Dumont Aurélie, Pannier Diane, Ducoulombier Agnès, Tresch Emmanuelle, Chen Jinying, Kramar Andrew, Révillion Françoise, Peyrat Jean-Philippe, Bonneterre Jacqu |
Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy. Pharmacogenetics and genomics 2015 Dec . Park Hyung Soon, Lim Sun Min, Cho Arthur, Shin Jae-Gook, Lee Min Goo, Kim Hye Ryun, Kim Joo Hang, Shin Ho Jung, Cho Byoung Ch |
Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity. Pharmacogenomics 2016 09 17 (14): 1483-90. Bins Sander, Lenting Anne, El Bouazzaoui Samira, van Doorn Leni, Oomen-de Hoop Esther, Eskens Ferry Alm, van Schaik Ron Hn, Mathijssen Ron |
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese. Cancer chemotherapy and pharmacology 2017 Apr . Tanabe Yuko, Shimizu Chikako, Hamada Akinobu, Hashimoto Kenji, Ikeda Kazutaka, Nishizawa Daisuke, Hasegawa Junko, Shimomura Akihiko, Ozaki Yukinori, Tamura Nobuko, Yamamoto Harukaze, Yunokawa Mayu, Yonemori Kan, Takano Toshimi, Kawabata Hidetaka, Tamura Kenji, Fujiwara Yasuhi |
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
Breast cancer research and treatment 2017 Apr . Dudenkov Tanda M, Ingle James N, Buzdar Aman U, Robson Mark E, Kubo Michiaki, Ibrahim-Zada Irada, Batzler Anthony, Jenkins Gregory D, Pietrzak Tracy L, Carlson Erin E, Barman Poulami, Goetz Matthew P, Northfelt Donald W, Moreno-Aspita Alvaro, Williard Clark V, Kalari Krishna R, Nakamura Yusuke, Wang Liewei, Weinshilboum Richard |
[Association study of genetic variations in SLCO1B3 gene with prognosis in breast cancer patients treated with neoadjuvant chemotherapy of TA regimen]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2019 8 41 (8): 587-593. Du Z L, Xu C S, Bian Z M, Peng M T, Li C B, Feng T, Xu X Z, Liu H J, Zhang B |
Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study.
Epidemiology and health 2019 41 e2019034. Jeon Christina, Lee Ji-Young, Lee Sun Ju, Jung Keum Ji, Kimm Heejin, Jee Sun |
The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer. Cancer chemotherapy and pharmacology 2020 Jan . Belderbos Bodine P S, de With Mirjam, Singh Rajbir K, Agema Bram C, El Bouazzaoui Samira, Oomen-de Hoop Esther, de Wit Ronald, van Schaik Ron H N, Mathijssen Ron H J, Bins Sand |
Genome-Wide Identification of m6A-Associated Single-Nucleotide Polymorphisms in Colorectal Cancer. Pharmacogenomics and personalized medicine 2021 14 887-892. Zhao Hongying, Jiang Jinying, Wang Mingshan, Xuan Zix |
Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. The pharmacogenomics journal 2021 3 21 (3): 336-345. van Eijk Maarten, Pluim Dick, Dorlo Thomas P C, Marchetti Serena, Huitema Alwin D R, Beijnen Jos |
Polymorphisms in solute carrier genes (SLC19A1, SLCO1B1, and SLCO1B3) predicts survival and toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of clinical pharmacy and therapeutics 2022 Jul . Sharma Parul, Singh Navneet, Sharma Siddhar |
A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma. Frontiers in cell and developmental biology 2022 3 10 730132. Zhang Kai, Qian Ying, Quan Xiaowei, Zhu Tengteng, Qian Biy |
Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high-grade serous ovarian cancer. Basic & clinical pharmacology & toxicology 2023 3 . Deng Feng, Laasik Maren, Salminen Liina, Lapatto Lauri, Huhtinen Kaisa, Li Yilin, Hautaniemi Sampsa, Hynninen Johanna, Niemi Mikko, Lehtonen Rain |
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer. Pharmaceutics 2023 2 15 (2): . Ferrero Jean-Marc, Mahammedi Hakim, Gravis Gwenaelle, Roubaud Guilhem, Beuzeboc Philippe, Largillier Remi, Borchiellini Delphine, Linassier Claude, Ebran Nathalie, Pace-Loscos Tanguy, Etienne-Grimaldi Marie-Christine, Schiappa Renaud, Gal Jocelyn, Milano Géra |
SLCO1B3 and SLCO2B1 Genotypes, Androgen Deprivation Therapy, and Prostate Cancer Outcomes: A Prospective Cohort Study and Meta-analysis. Carcinogenesis 2023 10 . S Harisha Rajanala, Anna Plym, J Bailey Vaselkiv, Ericka M Ebot, Konstantina Matsoukas, Zhike Lin, Goutam Chakraborty, Sarah C Markt, Kathryn L Penney, Gwo-Shu Mary Lee, Lorelei A Mucci, Philip W Kantoff, Konrad H Stopsa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: